CORDIS
EU research results

CORDIS

English EN

New strategies for treatment and prevention of mycobacterial diseases

Project information

Grant agreement ID: QLK2-CT-2000-01761

  • Start date

    1 December 2000

  • End date

    1 December 2004

Funded under:

FP5-LIFE QUALITY

  • Overall budget:

    € 2 377 436

  • EU contribution

    € 1 743 126

Coordinated by:

HANNOVER MEDICAL SCHOOL

Germany

Objective

Recent progress in the fields of epidemiology, biochemistry and mycobacterium genetics provide exciting new opportunities for developing new strategies for prevention and treatment of mycobacterium diseases. The proposed TB Prevention Cluster provides multidisciplinary European approach based on an integrated, goal-oriented strategy. The Cluster combines three areas of fundamental importance to tackle the problem of tuberculosis: (I) cell wall structure, permeability and innate drug resistance; (ii) novel drug targets;(iii) transmissibility and prevention strategies. The overall goal of the Cluster is to contribute to strategies for preventing spread of resistance, to identify strategies to overcome innate mycobacterium drug resistance, to characterize targets for future drug design, to develop more effective tools for epidemiological monitoring and for diagnosis of infection, to identify factors determining transmission. The outcomes of the Cluster contributing to more effective measurements for prevention of tuberculosis and fuelling into strategies for optimal use of existing antimycobacterial agents and identification of novel targets for anti-infective drugs would have a major impact on tuberculosis control in the European Union and worldwide.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

HANNOVER MEDICAL SCHOOL

Address

Carl-Neuberg-Strasse 1
30625 Hannover

Germany

Participants (15)

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

France

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

United Kingdom

INSTITUT PASTEUR

France

KAROLINSKA INSTITUTE

Sweden

MRC National Institute for Medical Research

United Kingdom

RUSSIAN ACADEMY OF MEDICAL SCIENCES - CENTRAL INSTITUTE FOR SCIENTIFIC RESEARCH IN TUBERCULOSIS

Russia

THE UNIVERSITY OF MILANO

Italy

UNIVERSIDAD DE ZARAGOZA

Spain

UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE 'AMEDEO AVOGADRO'

Italy

UNIVERSITA DEGLI STUDI DI PAVIA

Italy

UNIVERSITA POLITECNICA DELLE MARCHE

Italy

UNIVERSITE PAUL SABATIER DE TOULOUSE III

France

UNIVERSITY OF ERLANGEN-NUREMBERG

Germany

UNIVERSITY OF SURREY

United Kingdom

UNIVERSITY OF ZURICH

Switzerland

Project information

Grant agreement ID: QLK2-CT-2000-01761

  • Start date

    1 December 2000

  • End date

    1 December 2004

Funded under:

FP5-LIFE QUALITY

  • Overall budget:

    € 2 377 436

  • EU contribution

    € 1 743 126

Coordinated by:

HANNOVER MEDICAL SCHOOL

Germany